SOURCE: Hansen Medical, Inc.

Hansen Medical, Inc.

October 20, 2014 16:05 ET

Hansen Medical Appoints Brian Sheahan as Vice President of Clinical, Regulatory and Quality Affairs

MOUNTAIN VIEW, CA--(Marketwired - Oct 20, 2014) - Hansen Medical, Inc. (NASDAQ: HNSN), a global leader in intravascular robotics, today announced it has named Brian Sheahan as Vice President of Clinical, Regulatory and Quality Affairs. Mr. Sheahan will report directly to Hansen's President and Chief Executive Officer, Cary Vance.

"I'm delighted to announce Brian's appointment as Vice President of Clinical, Regulatory and Quality Affairs," said Cary Vance, CEO. "Brian brings extensive clinical expertise which we will leverage as Hansen continues to gather data to confirm its product platform."

Mr. Sheahan joins Hansen with more than 25 years of experience in the medical device field. Most recently, he served as Senior Vice President of Clinical and Regulatory Affairs and Quality Assurance for Direct Flow Medical, Inc. where he was responsible for all U.S & E.U. field and in-house clinical operations, regulatory affairs and quality assurance. Prior to Direct Flow Medical, he also held similar roles at TriVascular, Arterial Vascular Engineering Inc. and PS Medical, Inc. Mr. Sheahan holds a Bachelor of Science from Saint Joseph's University in Philadelphia.

About Hansen Medical, Inc.
Hansen Medical, Inc., based in Mountain View, California, is a global leader in Intravascular Robotics, developing products and technology designed to enable the accurate positioning, manipulation and control of catheters and catheter-based technologies. The Company's Magellan™ Robotic System, 9Fr Magellan™ Robotic Catheter, Magellan™ 6Fr Robotic Catheter, and related accessories are intended to facilitate navigation to anatomical targets in the peripheral vasculature and subsequently provide a conduit for manual placement of therapeutic devices. The Company's mission is to enable Cardiac Arrhythmia and Endovascular Procedures and to improve patient outcomes through the use of Intravascular Robotics. Additional information can be found at

"Artisan Extend," "Hansen Medical," "Hansen Medical (with Heart Design)," "Heart Design (Logo)," "Sensei," "Lynx," "Artisan," "Instinctive Motion," "Fine Force Technology," "IntelliSense" are registered trademarks, and "Magellan" and "Hansen Medical Magellan" are trademarks of Hansen Medical, Inc. in the U.S. and other countries.

Contact Information

  • Investor Contacts:
    Chris Lowe
    Interim Chief Financial Officer
    Hansen Medical, Inc.
    Email Contact